COCRYSTAL PHARMA, INC. Loss Contingency, Damages Sought, Value
COCRYSTAL PHARMA, INC. (COCP) reported Loss Contingency, Damages Sought, Value of $1.00 million for the 0-month period ending 2020-05-19, per its 10-Q filed 2021-08-16.
Discontinued › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyDamagesSoughtValue · last filed 2021-08-16
- COCRYSTAL PHARMA, INC. loss contingency, damages sought, value for fiscal 2012 was $2.00M.
| Period end | Loss Contingency, Damages Sought, Value 0 month | Loss Contingency, Damages Sought, Value 9 month | Loss Contingency, Damages Sought, Value 12 month |
|---|---|---|---|
| 2020-05-19 | $1.00M 10-Q · filed 2021-08-16 | ||
| 2014-09-30 | $3.04M 10-Q · filed 2014-11-14 | ||
| 2012-12-31 | $2.00M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |